BerandaBAVA • CPH
add
Bavarian Nordic A/S
Tutup sebelumnya
kr 185,20
Rentang hari
kr 184,20 - kr 187,80
Rentang tahun
kr 125,55 - kr 194,00
Kapitalisasi pasar
14,47 M DKK
Volume Rata-Rata
405,25 rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (DKK) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 831,47 jt | -33,59% |
Biaya operasional | 394,13 jt | -13,17% |
Laba bersih | -114,45 jt | -130,41% |
Margin laba bersih | -13,76 | -145,78% |
Penghasilan per saham | -1,50 | -129,41% |
EBITDA | 21,84 jt | -95,46% |
Tarif pajak efektif | -0,27% | — |
Neraca
Total aset
Total liabilitas
| (DKK) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,29 M | -22,87% |
Total aset | 13,62 M | 3,34% |
Total liabilitas | 3,45 M | -15,11% |
Total ekuitas | 10,17 M | — |
Saham yang beredar | 76,30 jt | — |
Harga terhadap reservasi | 1,39 | — |
Tingkat pengembalian aset | -2,30% | — |
Pengembalian modal | -3,10% | — |
Arus Kas
Perubahan bersih tunai
| (DKK) | Mar 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -114,45 jt | -130,41% |
Kas dari operasi | 435,23 jt | 302,72% |
Tunai dari investasi | -1,05 M | -415,81% |
Tunai dari pembiayaan | -10,73 jt | -101,84% |
Perubahan bersih tunai | -616,42 jt | -188,53% |
Arus kas bebas | 1,25 M | 475,41% |
Tentang
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with a manufacturing facility in Kvistgård, and an additional site in Hørsholm. The company has a research and development facility in Martinsried, Germany, and offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors in its research and development. Wikipedia
CEO
Didirikan
1 Jul 1992
Situs
Karyawan
1.381
